According to the recent research report titled ‘Cell Harvesting Systems Market Share, Size, Trends, Industry Analysis Report By Techniques; By Application; By End User; By Regions, Segment Forecast, 2020 – 2026’, available with Market Study Report, global cell harvesting systems market is projected to be valued at USD 11.7 billion by the year 2026.
 

Increasing investments in regenerative and cell science, expanding biotechnology industries, along with escalating instances of chronic and infectious diseases are the key factors propelling global cell harvesting systems market growth. Moreover, rising transplant, rate and mounting demand for stem cell banking are also adding to the overall market outlook.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2963757/
 

Growing cases of chronic illnesses caused by age and lifestyle, has resulted in escalating expenditure on healthcare. Rapid urbanization, changing diets, sedentary lifestyles, rising obesity rates, and easier access to tobacco products are the leading causes of death in developing economies. The potential of stem cells in treating several chronic diseases is a key driver of worldwide cell harvesting systems industry expansion.
 

Furthermore, demand for cell harvesting systems is increasing with bone marrow transplantation procedures becoming more common due to rising prevalence of blood cancer and anemia. Increased healthcare spending per capita, improved post-therapy survival rate, surge in logistics investment, extended cardiovascular transplantation recording, and rising neuronal illness cases are also swaying the business dynamics.
 

Coming to the restraints, hefty treatment costs, immunosuppression, dearth of recovery measures, insufficient transplant HSC cells, in consort with issues in recognition of stem cells in adult tissues, feasible cell density, and cell-cell problems are negatively impacting worldwide cell harvesting industry share.
 

From the geographical front, North America is predicted to hold significant portion of global cell harvesting systems market share by the year 2027, creditable to rising research spending and government initiatives in the US. Notably, the only FDA-approved stem cell products in the United States are blood-forming stem cells derived from cord blood. These, along with bone marrow stem cells, are often used in transplant procedures to treat cancer and immune and blood system disorders in patients.
 

Major firms influencing global cell harvesting systems market trends are Teleflex Incorporated, SP Scienceware, Argos Technologies Inc., Avita Medical, HynoDent AG, Terumo BCT Inc., Bertin Technologies SAS, Tomtec, and PerkinElmer Inc.